Zevra Therapeutics, Inc. (ZVRA)
12.06
+0.32
(+2.73%)
USD |
NASDAQ |
Sep 01, 16:00
12.06
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Cash and Short Term Investments (Quarterly) : 221.57M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 221.57M |
| March 31, 2026 | 200.62M |
| December 31, 2025 | 191.01M |
| September 30, 2025 | 199.51M |
| June 30, 2025 | 202.61M |
| March 31, 2025 | 62.63M |
| December 31, 2024 | 69.50M |
| September 30, 2024 | 54.04M |
| June 30, 2024 | 39.26M |
| March 31, 2024 | 42.85M |
| December 31, 2023 | 43.05M |
| September 30, 2023 | 125.42M |
| June 30, 2023 | 87.37M |
| March 31, 2023 | 95.28M |
| December 31, 2022 | 65.95M |
| September 30, 2022 | 75.89M |
| June 30, 2022 | 80.98M |
| March 31, 2022 | 101.58M |
| December 31, 2021 | 112.35M |
| September 30, 2021 | 131.50M |
| June 30, 2021 | 132.30M |
| March 31, 2021 | 76.03M |
| December 31, 2020 | 4.322M |
| September 30, 2020 | 5.267M |
| Date | Value |
|---|---|
| June 30, 2020 | 6.369M |
| March 31, 2020 | 2.356M |
| December 31, 2019 | 3.217M |
| September 30, 2019 | 6.518M |
| June 30, 2019 | 7.308M |
| March 31, 2019 | 13.44M |
| December 31, 2018 | 21.67M |
| September 30, 2018 | 14.13M |
| June 30, 2018 | 29.30M |
| March 31, 2018 | 35.72M |
| December 31, 2017 | 43.33M |
| September 30, 2017 | 46.34M |
| June 30, 2017 | 54.59M |
| March 31, 2017 | 62.22M |
| December 31, 2016 | 68.86M |
| September 30, 2016 | 64.62M |
| June 30, 2016 | 83.74M |
| March 31, 2016 | 111.00M |
| December 31, 2015 | 51.32M |
| September 30, 2015 | 59.01M |
| June 30, 2015 | 64.22M |
| March 31, 2015 | 10.27M |
| December 31, 2014 | 10.26M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Innoviva, Inc. | 579.06M |
| Collegium Pharmaceutical, Inc. | 149.32M |
| Johnson & Johnson | 20.76B |
| Ligand Pharmaceuticals, Inc. | 1.358B |
| Harrow, Inc. | 83.89M |